Pharm Chem 3.14.22
Pharm Chem 3.14.22
Pharm Chem 3.14.22
Topics to Cover:
NEUROPATHIC
NOCICEPTIVE ★ Caused by nerve damage or disease that affects the
nervous system (diabetes, cancer, vitamin B deficiency,
★ Caused by tissue damage (cut, burn, HIV)
inflammation) ★ Associated with abnormal sensation
★ Peripheral nerve transfers the signal to the ★ Peripheral neuropathic pain: diabetes, herpes zoster
brain via the spinal cord infection, HIV-related neuropathies, nutritional
deficiencies, cancer
★ Pain signals are modulated throughout the ★ Central neuropathic pain: spinal cord injury, multiple
pathways sclerosis, stroke
★ ACUTE ★ CHRONIC
Opioid Peptide Receptors
● GCPR (G-coupled protein receptors) that are mainly distributed in the CNS
● 7 transmembrane domains
○ This means it crosses the cell membrane 7 times
● There are 4 types of opioid receptors
○ Mu-opioid
○ Kappa-opioid
○ Delta-opioid
○ Nociceptin receptor
Note: mu, kappa, and delta receptors → main fxn is to regulate pain
Naloxone acts quickly but does not last long (~1hr); naltrexone lasts for a day.
Top Hat
Question
1-4
02
Serotonergic
Neurochemistry
and Depression
Serotonin (5‐hydroxytryptamine, 5‐HT)
● Biosynthesis: serotonin is formed from the AA, tryptophan, in 2 steps
● Metabolism
○ Major metabolite = 5‐hydroindole acetic acid (5‐HIAA)
■ Monoamine oxidase (removes the amine) and aldehyde
dehydrogenase (converts -CHO into -COOH) are the 2 enzymes that
convert 5-HT into 5-HIAA
○ Minor metabolites = 5-hydroxytryptophol and Melatonin
Serotonin (5‐hydroxytryptamine, 5‐HT)
● Biological functions - its primary functions are performed in the BRAIN
○ Serotonin’s functions include: sleep, cognition, sensory perception, motor
activity, temperature regulation, nociception, mood, appetite, sexual
behavior, and hormone secretion.
● An imbalance (deficient) in serotonin levels may lead to depression!!
● There are 14 serotonin receptor subtypes
○ All of which are GCPRs
■ EXCEPT for 5-HT3 (5-HT3 is a ligand-gated ion channel)
○ 5‐HT1B and 5‐HT1D are auto-receptors (located on presynaptic cell &
regulate 5‐HT release)
○ 5‐HT1A and 5‐HT2A functions include: anxiety and depression
Clinical significance by affecting 5‐HT Signaling
● Selective serotonin reuptake inhibitors (SSRI), Serotonin norepinephrine
reuptake inhibitor (SNRI), and tricyclic antidepressants (TCA)
○ Inhibit 5-HT transporter (SERT)
■ Inhibition of SERT → increases levels of 5-HT in the synapse
Citalopram Escitalopram
Metabolism of Sertraline
FluvoxAmine
★ Approved to treat obsessive
compulsive disorder - FIRST
★ Has E configuration (E -
trans, Z - cis) only E (trans) Double bond E isomer
is on the market
★ More GI side effects than
other SSRIs
Chiral center
Removed
Fluoxetine
★ Sold as a racemic mixture
★ Metabolized in the liver by CYP2D6
★ Major metabolite is the demethylated-product, norfluoxetine
★ Both fluoxetine and norfluoxetine inhibit CYP2D6
★ Fluoxetine has an extremely long half-life (1-3 DAYS)
★ Less common to develop discontinuation syndrome due to long half life
★ KNOW:
○ Metabolite has about the same activity as the initial drug
○ Fluoxetine inhibits activity of enzyme used to metabolize it - this
slows/stops drug metabolism causing the drug to stay in the blood
longer
SNRIs
● Inhibit SERT and NET → cause enhanced serotonergic or noradrenergic
neurotransmission
○ Used for the treatment of depression, anxiety disorders, pain, etc.
● Examples: Venlafaxine, Desvenlafaxine, Duloxetine, Milnacipran, and
Levomilnacipran
Duloxetine: Duloxetine
● Examples:
○ Vilazodone: inhibits SERT + Partial agonist at 5‐HT1A + inhibit NET and
DAT
○ Vortioxetine: inhibits SERT + Agonist at 5‐HT1A + Antagonist at 5‐HT1D,
5‐HT3, 5‐HT7
5‐HT1 receptor agonists —Azapirones
● Used as add‐ons to other antidepressant, such as SSRIs
○ 5-HT1 receptor agonists are LESS EFFECTIVE than SSRIs
■ Examples:
● Buspirone, Gepirone, and Ipsapirone
● Metabolized in the liver
○ common metabolite is pyrimidinylpiperazine
Buspirone
Tranylcypromine
MAOIs
● Inhibiting MAO inhibits the body’s capacity to metabolize
endogenous monoamines NE and 5HT, but also exogenous biogenic
amines (ex: tyramine)
Phenelzine
○ Examples:
■ Tranylcypromine and Phenelzine: non-selective and
irreversible
■ Selegiline: selective and irreversible inhibitor of MAOB
● MAOIs and Tyramine:
○ Use of MAOI → increases BA of dietary tyramine → induces NE
release → increases BP
● As effective as TCAs, however they are rarely used due to:
○ Toxicity and DDIs
Top Hat
Question
7-10
04
Pharmacotherapy
of Psychosis
● Psychosis
○ Symptom of mental illness - distorted or Psychosis and the Dopamine
nonexistent sense of reality Hypothesis
○ Could include major depression or mania with
psychotic features
○
● Dopamine hypothesis:
○ Distrubed AND hyperactive dopaminergic signal
transduction, particularly prefrontal
hyperdopaminergia results in schizophrenia
symptoms
○ The dopamine hypothesis resulted in the
development of typical (1st generation)
antipsychotic agents AKA D2 antagonists
(because they stop the hyperactive dopaminergic
signal transduction!)
○ D2 antagonists have a HIGHER risk of EPSx
Atypical AKA 2nd Generation Antipsychotics
● These drugs are antagonists at 5-HT2A and D2, antagonists at
5-HT2A and partial agonist at D2
● These drugs have a LOWER potential for extrapyramidal (EPS)
side effects
● These drugs have a HIGHER concern for metabolic
dysregulation such as weight gain and T2DM
Top Hat
Question
11
Potency of 1st Potency of 2nd
Generation Generation
Haloperidol has the Clozapine was the first
highest binding affinity, atypical antipsychotic and
and thus the highest it targets both the D2 and
potency. 5-HT2A receptors
Representative
Structures Benzodiazepine
PheNothiaziNe
space
aryl
ThioXanthene
terminus
piperazine
Long-chain arylpiperazine
Examples: simple
focal seizure,
complex focal
seizure
Generalized Seizure :
both sides of the brain
A secondary generalized
Examples: tonic-clonic
seizure begins as a focal
and absence seizure
seizure and is followed by
a generalized seizure
Anti-seizure Drugs
Carbamazepine Barbiturates